insights_auto
Why is NOVOBN up ၅.၆၇%?
Dive Deeperchevron_right
NOVOBN:BMV
Novo Nordisk A/S
၇၆၄.၅၀ MX$
arrow_upward
+၅.၆၇%(+၄၁.၀၀) 1D
အောက် ၁၆, GMT-၆ ၁၄:၀၀:၀၀ · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOVOBN...
Open
၇၂၈.၀၀ MX$
High
၇၆၄.၅၀ MX$
Low
၇၂၈.၀၀ MX$
Mkt. cap
ဋေ ၁.၃၂ သ
Avg. vol.
၃၈၆.၀၀
Volume
၂၁.၀၀
52-wk high
၁,၁၄၉.၉၉ MX$
52-wk low
၆၃၀.၀၀ MX$
No. of employees
၇ သောင်း
Open
၇၂၈.၀၀ MX$
High
၇၆၄.၅၀ MX$
Low
၇၂၈.၀၀ MX$
Mkt. cap
ဋေ ၁.၃၂ သ
Avg. vol.
၃၈၆.၀၀
Volume
၂၁.၀၀
52-wk high
၁,၁၄၉.၉၉ MX$
52-wk low
၆၃၀.၀၀ MX$
No. of employees
၇ သောင်း
News stories
From web sources and news partners
Yahoo Finance
·
ပြီးခဲ့သည့် ၁၄ မိနစ်
Is Novo Nordisk (CPSE:NOVO B) Cheap After Lillys EMA Win Raised GLP 1 Pressure?
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ နာရီ
Is Novo Nordisk (CPSE:NOVO B) Facing A Bigger Threat In Europe?
The Motley Fool
·
ပြီးခဲ့သည့် ၃ နာရီ
Novo Trades at Less Than 12 Times Earnings. Is This the Buying Opportunity of the Decade?
Simply Wall Street
·
ပြီးခဲ့သည့် ၂၀ နာရီ
Novo Nordisk (NVO) Stock May Be Undervalued As Buybacks Continue
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
About Novo Nordisk A/S
CEOMike Doustdar
Employees၆.၆၇ သောင်း
Founded၁၉၂၃
HeadquartersBagsværd, Capital Region of Denmark, ဒိန်းမတ်
Sector-
Websitenovonordisk.com